Other

Treatment Stage
Protocol Title 
ClinicalTrials.Gov Link
Penn Research Coordinator 
Am I Eligible?
Recurrent A Phase 2 Study of XmAb®20717 in Patients With Selected Gynecological Malignancies and High-Risk Metastatic Castration-Resistant Prostate Cancer NCT05032040 Christine Pae Eligibility Criteria 
Prostate Cohort Only